Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 77771-175

This is a medication description for an extended-release tablet containing 100mg of bupropion hydrochloride. The usual dosage is not provided in the text and should be read on the accompanying prescribing information. The tablets should be stored at a controlled room temperature of 20°C to 25°C in a light-resistant container with a child-resistant closure. The medication should be kept out of the reach of children. The medication is manufactured by ScieGen Pharmaceuticals, and distributed by Radha Pharmaceuticals. The medication should not be used in combination with ZYBAN or any other medicines that contain bupropion hydrochloride.*

This is a medication description for Exch extended-release tablets that contain 100 mg of bupropion hydrochloride. The usual dosage and prescribing information should be carefully read. It should be stored at a controlled room temperature of 20°- 25°C (68-77°F) and kept out of reach of children. It is manufactured by ScieGen Pharmaceuticals and distributed by Radha Pharmaceuticals. It is a registered trademark of SlaoSmitKine. The medication should be dispensed in a high, light-resistant container with a child-resistant closure fastened as required. An accompanying medication guide should be given to each patient, and it shouldn't be used in combination with ZYBAN or any other medication that contains buproy (due to severe interactions).*

Each extended-release tablet contains 150 mg bupropion hydrochloride, USP. NDC 77771-175-05. Take Two-A-Day after initial titration. The usual dosage should be read by referring to the accompanying prescribing information. Store at 20° to 25°C (68° to 77°F) [see USP bupropion HCI controlled room temperature]. Extended-release tablets, USP (SR) should be dispensed in a tight, light-resistant container with a child-resistant closure as required to protect from light and moisture. Keep this and all medication out of the reach of children. Pharmacists should dispense the accompanying medication guide to each patient. ZYBAN® is a registered trademark of GlaxoSmithKline. WARNING: Do not use in combination with ZYBAN® or any other medicines that contain bupropion hydrochloride. Manufactured by ScieGen Pharmaceuticals, Inc. - Hauppauge, NY 11788 USA. Distributed by Radha Pharmaceuticals, Inc. - Hauppauge, NY 11788 USA. This is a prescription medication that contains 500 tablets.*

Each tablet of this medication contains 150 mg of bupropion hydrochloride, USP for extended-release purposes. The usual dosage should be obtained from the accompanying prescribing information. The medication should be stored in a container that is resistant to light and moisture and has a child-resistant closure at a controlled room temperature between 20°C and 25°C (68° and 77°F, following USP guidelines). It is important to keep the medication out of reach of children. ZYBAN® is a trademark of GlaucSmithine, and it should not be used together with this medication. ScieGen Pharmaceuticals, Inc manufactures it, and Radha Pharmaceuticas, Inc. distributes it. The NDC is 77771-175-60, and 60 tablets are available through a prescription.*

Edoh is a medication that comes in extended-release tablets containing 200 mg of bupropion hydrochloride, USP. The typical dosage for this medication can be found on the accompanying prescription information. It should be stored at room temperature in a child-resistant container and protected from moisture and light. It's essential to keep this medication out of children's reach, and it should not be used in combination with other medications containing bupropion hydrochloride, including ZYBAN®. This medication is manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY, and distributed by Radha Pharmaceuticals Inc. The package contains 60 tablets, and each patient should receive a medication guide with their prescription.*